Prospective Assessment of Stereotactic Ablative Surgery for Intractable Major Depression

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.
Biological psychiatry (Impact Factor: 9.47). 06/2008; 64(6):449-54. DOI: 10.1016/j.biopsych.2008.04.009
Source: PubMed

ABSTRACT Despite therapeutic advances for major depression, a subset of patients with this disorder does not respond to conventional treatment. Stereotactic ablative procedures such as anterior cingulotomy have been performed in severely affected, treatment-resistant patients, but the long-term results of such procedures are not fully understood.
Findings are reported for 33 patients with severe treatment-resistant major depression who underwent ablative stereotactic procedures (dorsal anterior cingulotomy followed if necessary by subcaudate tractotomy). Preoperative and long-term postoperative Beck Depression Inventory scores were obtained along with postoperative Clinical Global Improvement values. Both were analyzed to evaluate patients' responses to the surgical procedure(s).
At mean follow-up of 30 months after one or more stereotactic ablative procedures, 11 patients (33.3%) were classified as responders, 14 (42.4%) were partial responders, and 8 (24.2%) did not respond to the surgical procedure(s). Among those (17) who underwent only one procedure, seven (41.2%) responded, whereas six (35.3%) and four (23.5%) showed partial or no response, respectively. Among patients who required multiple surgical procedures, four patients (25%) responded, whereas eight (50%) and four (25%) patients demonstrated partial or no responses, respectively, at long-term follow-up evaluations.
Approximately 75% of depression patients previously resistant to antidepressant therapies received partial or substantial benefit from stereotactic ablative procedures. Those requiring only a single anterior cingulotomy tended to demonstrate more pronounced responses than patients who underwent multiple surgical procedures.

Download full-text


Available from: Wael F Asaad, Jul 31, 2015
  • Source
    • "Furthermore, the findings of this study accord with previous studies of neuroanatomically specific treatments for mood and anxiety disorders, such as psychosurgery and exogenous brain stimulation. Subcaudate tractotomy, a surgical procedure that interrupts white matter tracts connecting the vmPFC to subcortical structures, has shown efficacy in reducing symptoms of depression and anxiety (Cosgrove, 2000; Shields et al., 2008). And as would be predicted by the results of our study, vegetative symptoms of depression (e.g., changes in appetite, sleep, and energy) were less likely to improve with subcaudate tractotomy than depressed mood or anxiety (Hodgkiss et al., 1995). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The neuroanatomical correlates of depression remain unclear. Functional imaging data have associated depression with abnormal patterns of activity in prefrontal cortex (PFC), including the ventromedial (vmPFC) and dorsolateral (dlPFC) sectors. If vmPFC and dlPFC are critical neural substrates for the pathogenesis of depression, then damage to either area should affect the expression of depressive symptoms. Using patients with brain lesions we show that, relative to nonfrontal lesions, bilateral vmPFC lesions are associated with markedly low levels of depression, whereas bilateral dorsal PFC lesions (involving dorsomedial and dorsolateral areas in both hemispheres) are associated with substantially higher levels of depression. These findings demonstrate that vmPFC and dorsal PFC are critically and causally involved in depression, although with very different roles: vmPFC damage confers resistance to depression, whereas dorsal PFC damage confers vulnerability.
    The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 12/2008; 28(47):12341-8. DOI:10.1523/JNEUROSCI.2324-08.2008 · 6.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Advanced treatment options are available from a few tertiary centres for patients with the most severe and treatment-refractory forms of depression and obsessive–compulsive disorder. These treatments include ablative neurosurgery and electrical stimulation procedures directed against different neural targets. They include vagus nerve stimulation (VNS) and deep brain stimulation (DBS). Ablative procedures, such as anterior cingulotomy, are the best established of these alternatives, although the newer electrical stimulation procedures confer potential advantages with respect to surgical morbidity and reversibility. Whilst evidence for VNS as an effective therapy for depression is accruing, DBS remains an experimental treatment, with definitive evidence of efficacy awaited. All neurosurgical procedures used to treat psychiatric disorder should be provided by specialist multidisciplinary teams with expertise in the management of psychiatric disorder by pharmacological and psychological treatment methods. All psychiatric neurosurgical procedures should be subject to detailed long-term clinical audit to determine efficacy and adverse effect burden.
    Psychiatry 04/2009; 8(4):139-143. DOI:10.1016/j.mppsy.2009.01.007
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Posttraumatic stress disorder (PTSD) is characterized by recurrent distressing memories of an emotionally traumatic event. In this review, the authors present neuroscientific data highlighting the function of two brain areas--the amygdala and ventromedial prefrontal cortex (vmPFC)--in PTSD and related emotional processes. A convergent body of human and nonhuman studies suggests that the amygdala mediates the acquisition and expression of conditioned fear and the enhancement of emotional memory, whereas the vmPFC mediates the extinction of conditioned fear and the volitional regulation of negative emotion. It has been theorized that the vmPFC exerts inhibition on the amygdala, and that a defect in this inhibition could account for the symptoms of PTSD. This theory is supported by functional imaging studies of PTSD patients, who exhibit hypoactivity in the vmPFC but hyperactivity in the amygdala. A recent study of brain-injured and trauma-exposed combat veterans confirms that amygdala damage reduces the likelihood of developing PTSD. But contrary to the prediction of the top-down inhibition model, vmPFC damage also reduces the likelihood of developing PTSD. The putative roles of the amygdala and the vmPFC in the pathophysiology of PTSD, as well as implications for potential treatments, are discussed in light of these results.
    The Neuroscientist 05/2009; 15(5):540-8. DOI:10.1177/1073858409333072 · 7.62 Impact Factor
Show more